Is a complete ELTX research report available?

No complete published report is available for Elicio Therapeutics, Inc. (ELTX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Elicio Therapeutics, Inc. (ELTX)

NASDAQ: ELTX · USD

$2.91

+0.02 (+0.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ELTX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	68.2M
Net income (ttm)	-40.2M
EPS (ttm)	-$2.42
Shares out	23.5M
Volume	177,904
Beta	1.79
Price target	$20.0	+587.3%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -40.2M
EPS (ttm): -$2.42
Market cap: 68.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ELTX indicators

Market & fundamental data

Available fields

174

Groups with data

Currency

USD

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001555192
Company name	Elicio Therapeutics, Inc.
Country	United States
Country code	US
Cusip	28657F103
Employees	33
Employees Change	1%
Employees Change Percent	3.13
Enterprise value	$67.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US28657F1030
Last refreshed	2026-07-31
Market cap	$68.2M
Market cap category	Micro-Cap
Price	$2.91
Price currency	USD
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	2834
Symbol	ELTX
Website	https://elicio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-58.88%
FCF yield	-56.41%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-40.2M
Net Income Growth Years	1%
Profit Per Employee	$-1.2M
ROA	-92.41
Roa5y	-90.02
ROCE	-243.1
ROE	-1,076.3
ROIC	-170.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-71.21%
Cagr3y	-33.68%
EPS Growth Quarters	3
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$22.7M
Cash	$14.9M
Current Assets	$16.2M
Current Liabilities	$7.2M
Debt	$14.3M
Equity	$-1.4M
Interest Coverage	-27.55
Liabilities	$24.1M
Long Term Assets	$6.5M
Long Term Liabilities	$16.9M
Net Cash	$608,000
Net Cash By Market Cap	$0.89
Net Cash Growth	-95.16%
Tangible Book Value	$-1.4M
Tangible Book Value Per Share	$-0.08
WACC	12.93

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.24
Net Working Capital	$-4.9M
Quick ratio	2.07
Working Capital	$9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-29.18%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-71.19%
200-day SMA	8.87
3Y total return	-70.84%
50-day SMA	6.54
50-day SMA vs 200-day SMA	50under200
All Time High	24.39
All Time High Change	-88.07%
All Time High Date	2023-06-02
All Time Low	2.66
All Time Low Change	9.4%
All Time Low Date	2026-06-16
ATR	0.53
Beta	1.79
Beta1y	0.54
Beta2y	0.65
Ch YTD	-63.44
High	2.99
High52	16
High52 Date	2026-06-10
High52ch	-81.81%
Low	2.87
Low52	2.66
Low52 Date	2026-06-16
Low52ch	9.4%
Ma50ch	-55.52%
Price vs 200-day SMA	-67.18%
RSI	34.89
RSI Monthly	38.27
RSI Weekly	34.64
Sharpe ratio	-0.02x
Sortino ratio	0.01
Total Return	-29.18%
Tr YTD	-63.44
Tr1m	-27.25%
Tr1w	-7.62%
Tr3m	-71.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	3
Analyst Price Target Top	$17.5
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.54
Operating Income	$-37.6M
Price target	$20
Price Target Change	$587
Price Target Change Top	$501

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,150,365%
Float Percent	64.6%
Net Borrowing	9,866,000
Shares Insiders	24.22%
Shares Institutions	10.51%
Shares Out	23,451,939
Shares Qo Q	17.44%
Shares Yo Y	29.18%
Short Float	12.38%
Short Ratio	0.41
Short Shares	8

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-41.5M
Adjusted OCF	-41,526,000
Average Volume	931,644.25x
Bv Per Share	-0.08
CAPEX	$-16,000
Ch1m	-27.25
Ch1w	-7.62
Ch1y	-71.19
Ch3m	-71.8
Ch3y	-70.84
Ch6m	-63.99
Change	0.69%
Change From Open	-0.34
Close	2.89
Days Gap	1.04
Depreciation Amortization	197,000
Dollar Volume	517,700.6
Earnings Date	2026-08-07
Earnings Time	amc
EBIT	$-37.6M
EBITDA	$-36.4M
EPS	$-2.42
F Score	2
FCF	$-38.5M
FCF EV Yield	-56.91x
FCF Per Share	$-1.64
Financing CF	34,394,000
Fiscal Year End	December
Founded	2,011
Investing CF	-16,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2023-03-17
Ma150	8.85
Ma150ch	-67.11%
Ma20	3.13
Ma20ch	-7.09%
Net CF	-4,078,000
Next Earnings Date	2026-08-10
Open	2.92
Optionable	Yes
Position In Range	33.33
Post Close	2.91
Postmarket Change Percent	1.72
Postmarket Price	$2.96
Ppne	4,788,000
Price Date	2026-07-30
Relative Volume	0.19x
Share Based Comp	3,048,000
Tr6m	-63.99%
Us State	Massachusetts
Volume	177,904

Elicio Therapeutics, Inc. (ELTX)

Coverage state: Market snapshot only — no published research

Generate the first ELTX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ELTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ELTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ELTX

Frequently asked questions